HPV 6/11 Assay
Product Overview
The EasyNAT® Human Parvovirus B19 Assay is an automated, in vitro nucleic acid amplification test for the detection of low-risk types of HPV (HPV6 and HPV11) DNA in female endocervical and genitourinary tract specimens.
Results available within 51 minutes
Designed to provide an accurate LOD: 1000 copies/mL
Moderately complex testing with less than 1 minute of hands-on time
Ongoing Challanges
- HPV 6 and 11 are low-risk (LR) HPV types, but labeling them as “low-risk” is a significant part of the challenge.
- 90% of Anogenital Warts (Condylomata Acuminata) is the most common clinical manifestation of HPV 6/11.
- Anogenital warts cause substantial psychosocial distress, physical discomfort, and significant healthcare costs.
Clinical Value
Transforming the clinical pathway from a delayed, multi-visit process into a single, efficient, and definitive appointment.
Rapid, objective results facilitate better sexual health counseling and partner notification.
Designed for use in clinical laboratories as well as near-patient settings.
Product Resources
EasyNAT® Human Parvovirus B19 Assay
Brochure
